Overview: Respiratory Syncytial Virus (RSV) Antigen Rapid TestIntroduction: The Respiratory Syncytial Virus (RSV) Antigen Rapid Test is a diagnostic tool designed to detect RSV antigens in nasopharyngeal, nasal swabs, or saliva samples, facilitating the screening of RSV infections. Caused by the respiratory syncytial virus, this common respiratory infection presents with cough, wheezing, and severe complications like bronchiolitis or pneumonia if untreated, particularly in infants, the elderly, or immunocompromised individuals. Per the 2023 Centers for Disease Control and Prevention guidelines, the test employs immunochromatographic technology, delivering results within 15-20 minutes with high sensitivity and specificity, making it a critical tool for rapid diagnosis during seasonal outbreaks. This rapid diagnostic falls under virology and targets individuals with respiratory symptoms, addressing the challenge of distinguishing RSV from other respiratory viruses to guide supportive care and antiviral use like palivizumab in high-risk cases. With morbidity rates elevated during winter months, the test supports public health efforts by enabling early detection, facilitating isolation, and promoting preventive measures. Its multi-sample capability enhances its utility.Other Names: RSV Rapid Test.FDA Status: FDA approved, CLIA certified for virology, compliant with 2025 standards.Historical Milestone: Introduced in the 2000s by Quidel, this test advanced RSV detection, providing a rapid alternative to viral culture.Purpose: The test screens for RSV antigens to guide infection diagnosis, assess disease severity, and inform treatment and prevention strategies.Test Parameters: Presence of RSV Antigen, detected with high specificity to indicate active infection, typically detectable during the acute phase, peaking within 2-5 days of symptom onset.Pretest Condition: No fasting required; patients should avoid food or drink for 30 minutes prior to collection to ensure sample integrity, and they should report cough, wheezing, or recent respiratory illness.Specimen: Nasopharyngeal Swab 1-2 swabs, Nasal Swab 1-2 swabs, Saliva 1-2 mL, collected using sterile swabs/transport medium or containers, transported within 24 hours to maintain sample viability.Sample Stability at Room Temperature: 24 hours with proper handling in a cool environment to preserve antigen integrity, ensuring reliable test performance.Sample Stability at Refrigeration: 48 hours at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.Sample Stability at Frozen: Not recommended, as freezing may denature antigens, increasing the risk of false negatives and compromising diagnostic accuracy.Medical History: Patients should provide details on cough, wheezing, respiratory distress, or prior RSV infections, as well as any age-related risks or immunosuppression.Consent: Written informed consent is required, detailing the test's purpose, potential risks of untreated infection including pneumonia, benefits of early detection, and minimal discomfort from sample collection.Procedural Considerations: The test utilizes an immunochromatographic cassette requiring trained personnel to ensure sterile technique, avoid contamination, and interpret results within 15-20 minutes using provided positive and negative controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols, and store test kits according to manufacturer specifications to ensure reliability.Factors Affecting Result Accuracy: Delays beyond 24 hours, improper storage conditions, cross-contamination with other samples, or late infection after antigen clearance can affect results. Correlation with PCR or viral culture is recommended to confirm findings.Clinical Significance: A positive result indicates RSV infection, necessitating supportive care and isolation. A negative result may require follow-up testing if symptoms persist, especially if sampled outside the antigen peak window.Specialist Consultation: Pediatricians or infectious disease specialists should be consulted for case management, treatment planning, and coordination with public health authorities.Additional Supporting Tests: RSV PCR, viral culture, or serology for confirmation.Test Limitations: The test may produce false negatives in late infection or false positives due to cross-reactivity, requiring a comprehensive diagnostic approach that includes molecular methods.References: CDC Guidelines 2023, Journal of Clinical Virology 2024, Pediatrics 2025.